Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Gasca-Capote

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in HIV and AIDS|January 8, 2025
Persistent elite controllers as the key model to identify permanent HIV remissionCarmen Gasca-Capote, Ezequiel Ruiz-Mateos
Antibiotics (Basel, Switzerland)|August 27, 2021
Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant <i>Staphylococcus aureus</i>Cristina Velázquez-Suárez, Rubén Cebrián, Carmen Gasca-Capote, et al.
The Journal of Experimental Medicine|October 28, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infectionWeiwei Sun, Ce Gao, Gregory Takashi Gladkov, et al.
JCI Insight|October 28, 2025
Viral reservoir characteristics in lymphoid tissues of HIV-1 elite controllersSamantha K Marzi, Chloé M Naasz, Leah Carrere, et al.
Ebiomedicine|September 12, 2024
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1Esperanza Muñoz-Muela, María Trujillo-Rodríguez, Ana Serna-Gallego, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 31, 2025
Maraviroc treatment for hospitalized participants with non-severe COVID-19 at risk of progression: a randomized, proof-of-concept clinical trialCarmen Gasca-Capote, José Manuel Lomas-Cabezas, Abraham Saborido-Alconchel, et al.
JCI Insight|August 9, 2022
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged peopleJoana Vitallé, Alberto Pérez-Gómez, Francisco José Ostos, et al.
Plos One|July 14, 2022
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Plos One|November 21, 2024
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Frontiers in Immunology|May 7, 2025
SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesiclesSara Bachiller, Joana Vitallé, Lluís Camprubí-Ferrer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in HIV and AIDS|January 8, 2025
Persistent elite controllers as the key model to identify permanent HIV remissionCarmen Gasca-Capote, Ezequiel Ruiz-Mateos
Antibiotics (Basel, Switzerland)|August 27, 2021
Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant <i>Staphylococcus aureus</i>Cristina Velázquez-Suárez, Rubén Cebrián, Carmen Gasca-Capote, et al.
The Journal of Experimental Medicine|October 28, 2024
Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infectionWeiwei Sun, Ce Gao, Gregory Takashi Gladkov, et al.
JCI Insight|October 28, 2025
Viral reservoir characteristics in lymphoid tissues of HIV-1 elite controllersSamantha K Marzi, Chloé M Naasz, Leah Carrere, et al.
Ebiomedicine|September 12, 2024
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1Esperanza Muñoz-Muela, María Trujillo-Rodríguez, Ana Serna-Gallego, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 31, 2025
Maraviroc treatment for hospitalized participants with non-severe COVID-19 at risk of progression: a randomized, proof-of-concept clinical trialCarmen Gasca-Capote, José Manuel Lomas-Cabezas, Abraham Saborido-Alconchel, et al.
JCI Insight|August 9, 2022
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged peopleJoana Vitallé, Alberto Pérez-Gómez, Francisco José Ostos, et al.
Plos One|July 14, 2022
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Plos One|November 21, 2024
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Frontiers in Immunology|May 7, 2025
SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesiclesSara Bachiller, Joana Vitallé, Lluís Camprubí-Ferrer, et al.
Pageof 2